Hiroko Endo
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Cancer, Hypoxia, and Metabolism 14
- Cancer Genomics and Diagnostics 4
- Oncology 24
- Cancer Cells and Metastasis 15
- Co-authors
- Masahiro InoueHiroaki OkuyamaMasayuki OhueJumpei KondoOsamu IshikawaMasahiko TsujiiHiroyasu IishiKikuya Kato
- Journals
- Cancer Science (9 papers)Bulletin of the Chemical Society of Japan (7 papers)Cancer Research (6 papers)Journal of Clinical Investigation (3 papers)PLoS ONE (3 papers)
- Partner nations
- JapanUnited StatesRussia
In The Last Decade
Hiroko Endo
75 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 131
- Cancer Research 446
- Oncology 791
- Biotechnology 115
- Molecular Biology 827
- Cell Biology 179
Countries citing papers authored by Hiroko Endo
This map shows the geographic impact of Hiroko Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Endo more than expected).
Fields of papers citing papers by Hiroko Endo
This network shows the impact of papers produced by Hiroko Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Endo. The network helps show where Hiroko Endo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroko Endo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 7 | |
| 4 | 2020 | 6 | |
| 5 | 2018 | 124 | |
| 6 | 2018 | 102 | |
| 7 | 2016 | 13 | |
| 8 | 2015 | 11 | |
| 9 | 2015 | 23 | |
| 10 | 2014 | 2 | |
| 11 | 2013 | 0 | |
| 12 | 2011 | 255 | |
| 13 | 2011 | 137 | |
| 14 | 2010 | 83 | |
| 15 | 2010 | 41 | |
| 16 | 2008 | 9 | |
| 17 | 2007 | 33 | |
| 18 | 2003 | 111 | |
| 19 | Acute otitis media associated with influenza virus infection | 2003 | 3 |
| 20 | 1995 | 2 |
About Hiroko Endo
Hiroko Endo is a scholar working on Cancer Research, Oncology, Leadership and Management, Otorhinolaryngology and Biotechnology, having authored 81 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (15 papers), Cancer, Hypoxia, and Metabolism (14 papers), Cancer Research and Treatments (5 papers), Cancer Genomics and Diagnostics (4 papers), 3D Printing in Biomedical Research (4 papers), Respiratory viral infections research (4 papers), Pneumonia and Respiratory Infections (4 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Cancer Research (446 citations), Oncology (791 citations), Biotechnology (115 citations), Molecular Biology (827 citations) and Cell Biology (179 citations). Hiroko Endo has collaborated with scholars based in Japan, United States and Russia. Frequent co-authors include Masahiro Inoue, Hiroaki Okuyama, Masayuki Ohue, Jumpei Kondo, Osamu Ishikawa, Masahiro Inoue, Masahiko Tsujii, Hiroyasu Iishi, Kikuya Kato and Mutsuko Mukai. Their work appears in journals such as Cancer Science, Bulletin of the Chemical Society of Japan, Cancer Research, Journal of Clinical Investigation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.